AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34515341 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology (higher dose after nonresponse)
Number of subjects: 300
Study 34515341 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditative practices (higher dose after nonresponse)
Number of subjects: 300
Study 34515341 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 32220916 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide 1.2 mg/day (LIRA)
Number of subjects: 45
Study 32220916 — intervention group
Group type: EXPERIMENTAL
Intervention: canagliflozin 100 mg/day (CANA)
Number of subjects: 45
Study 32220916 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide 1.2 mg plus canagliflozin 100 mg (CANA/LIRA)
Number of subjects: 45
Study 35213554 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA-assisted therapy (MDMA-AT)
Number of subjects: 90
Study 35213554 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 90
Study 33642523 — intervention group
Group type: EXPERIMENTAL
Intervention: SO‐1105 (Miconazole Mucoadhesive Tablets)
Number of subjects: 120
Study 33642523 — intervention group
Group type: COMPARATOR
Intervention: Miconazole Gel
Number of subjects: 120
Study 32677897 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week multimodal exercise program (MEP)
Number of subjects: 319
Study 32677897 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control group, n=118)
Number of subjects: 319
Study 34100241 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric co-management combined with interdisciplinary transitional care
Number of subjects: 240
Study 34100241 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 240
Study 33731291 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous volar nerve block (one-injection)
Number of subjects: 409
Study 33731291 — intervention group
Group type: COMPARATOR
Intervention: Traditional dorsal digital nerve block (two-injection)
Number of subjects: 409
Study 33731291 — intervention group
Group type: COMPARATOR
Intervention: Traditional dorsal digital nerve block
Number of subjects: 409
Study 33731291 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous volar nerve block
Number of subjects: 409
Study 33383954 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral formula plus one sachet/day of synbiotic for four months
Number of subjects: 20
Study 33383954 — intervention group
Group type: COMPARATOR
Intervention: Enteral formula (control group) for four months
Number of subjects: 20
Study 33383954 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic administration
Number of subjects: 20
Study 33383954 — intervention group
Group type: EXPERIMENTAL
Intervention: Methanobrevibacter growth
Number of subjects: 20
Study 36349596 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (2 mg) and intranasal oxytocin (24 IU)
Number of subjects: 226
Study 36349596 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal placebo and intranasal oxytocin
Number of subjects: 226
Study 36349596 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol and intranasal placebo
Number of subjects: 226
Study 36349596 — intervention group
Group type: COMPARATOR
Intervention: Transdermal placebo and intranasal placebo
Number of subjects: 226
Study 34901264 — intervention group
Group type: EXPERIMENTAL
Intervention: IV hydrocortisone administration prior to hemodialysis for 3 consecutive sessions
Number of subjects: 14
Study 34901264 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 ml saline) administered during 3 intervention-free sessions
Number of subjects: 14
Study 35397973 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) glasses
Number of subjects: 96
Study 35397973 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Balls (SB)
Number of subjects: 96
Study 35397973 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 34473906 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV immunoprophylaxis with palivizumab
Number of subjects: 429
Study 34473906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study 32108732 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferential current (IC) - eight electrotherapy sessions twice a week
Number of subjects: 40
Study 32108732 — intervention group
Group type: COMPARATOR
Intervention: Topical estriol (E) - vaginal cream, daily application, 0.5 mg/d
Number of subjects: 40
Study 35062340 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone in addition to oral prednisolone therapy
Number of subjects: 38
Study 35062340 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone
Number of subjects: 38
Study 35062340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 33780106 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg plus Tamsulosin 0.4 mg
Number of subjects: 80
Study 33780106 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg plus capsule lactobacillus (placebo)
Number of subjects: 80
Study 36209193 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperation condition
Number of subjects: 40
Study 36209193 — intervention group
Group type: COMPARATOR
Intervention: Solo condition
Number of subjects: 40
Study 36209193 — intervention group
Group type: COMPARATOR
Intervention: Parallel condition
Number of subjects: 40
Study 32902808 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 2325
Study 32902808 — intervention group
Group type: COMPARATOR
Intervention: Control (no tranexamic acid)
Number of subjects: 2325
Study 32902808 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurological deterioration
Number of subjects: 2325
Study 32225032 — intervention group
Group type: EXPERIMENTAL
Intervention: Promotion of red peppers by a popular social influencer on Instagram (n = 44)
Number of subjects: 132
Study 32225032 — intervention group
Group type: EXPERIMENTAL
Intervention: Promotion of energy-dense snacks by a popular social influencer on Instagram (n = 44)
Number of subjects: 132
Study 32225032 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 44)
Number of subjects: 132
Study 36350651 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth+I group (mHealth app + nurse case management)
Number of subjects: 221
Study 36350651 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth group (mHealth app only)
Number of subjects: 221
Study 36350651 — intervention group
Group type: COMPARATOR
Intervention: mHealth+I group
Number of subjects: 221
Study 32916329 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with dental scaling (DS)
Number of subjects: 30
Study 32916329 — intervention group
Group type: COMPARATOR
Intervention: Dental scaling (DS) alone
Number of subjects: 30
Study 35820757 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhan Zhuang Qigong exercises (5 times a week, 30 min each, for 8 weeks)
Number of subjects: 72
Study 35820757 — intervention group
Group type: COMPARATOR
Intervention: Conventional medicine
Number of subjects: 72
Study 33291058 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for co-occurring traumatic stress and substance use (details on dosage and duration not available)
Number of subjects: 135
Study 32522498 — intervention group
Group type: EXPERIMENTAL
Intervention: Domagrozumab (5, 20, and 40 mg/kg)
Number of subjects: 120
Study 32522498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 32522498 — intervention group
Group type: EXPERIMENTAL
Intervention: Domagrozumab
Number of subjects: 120
Study 35513842 — intervention group
Group type: EXPERIMENTAL
Intervention: $333 monthly cash gift
Number of subjects: 1000
Study 35513842 — intervention group
Group type: COMPARATOR
Intervention: $20 monthly cash gift (Control)
Number of subjects: 1000
Study 33861547 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis‐3 criteria
Number of subjects: 5215
Study 33861547 — intervention group
Group type: EXPERIMENTAL
Intervention: Angus infection criteria
Number of subjects: 5215
Study 33861547 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhee criteria
Number of subjects: 5215
Study 33861547 — intervention group
Group type: EXPERIMENTAL
Intervention: Angus criteria
Number of subjects: 5215
Study 35779242 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole 5 mg/day
Number of subjects: 25
Study 35779242 — intervention group
Group type: COMPARATOR
Intervention: Control (no letrozole)
Number of subjects: 25
Study 33822396 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive BP lowering strategy (SBP <120 mmHg) with ACEi/ARBs plus thiazides
Number of subjects: 9361
Study 33822396 — intervention group
Group type: COMPARATOR
Intervention: Standard BP lowering strategy
Number of subjects: 9361
Study 33822396 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (SBP <120 mmHg)
Number of subjects: 9361
Study 32074143 — intervention group
Group type: EXPERIMENTAL
Intervention: Carica papaya leaf extract (CPLE)
Number of subjects: 51
Study 32074143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 35739000 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative EA (B)
Number of subjects: 144
Study 35739000 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of preoperative and intraoperative EA (D)
Number of subjects: 144
Study 35739000 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative EA (C)
Number of subjects: 144
Study 35739000 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (A)
Number of subjects: 144
Study 33098114 — intervention group
Group type: EXPERIMENTAL
Intervention: Group prenatal care (PNC)
Number of subjects: 218
Study 33098114 — intervention group
Group type: COMPARATOR
Intervention: Individual prenatal care (PNC)
Number of subjects: 218
Study 34719443 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue (MB)
Number of subjects: 30
Study 34719443 — intervention group
Group type: COMPARATOR
Intervention: Terlipressin (TP)
Number of subjects: 30
Study 34490739 — intervention group
Group type: EXPERIMENTAL
Intervention: Total BCAA level increase
Number of subjects: 0
Study 34490739 — intervention group
Group type: COMPARATOR
Intervention: BMI variants increase
Number of subjects: 0
Study 32706159 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g okra powder blended in 150 g conventional yogurt
Number of subjects: 60
Study 32706159 — intervention group
Group type: COMPARATOR
Intervention: Conventional yogurt alone
Number of subjects: 60
Study 35876385 — intervention group
Group type: EXPERIMENTAL
Intervention: FLOT
Number of subjects: 222
Study 35876385 — intervention group
Group type: COMPARATOR
Intervention: CROSS
Number of subjects: 222
Study 33305542 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine extended-release (GXR)
Number of subjects: 200
Study 33305542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 35491383 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional (3D) visualisation
Number of subjects: 0
Study 35491383 — intervention group
Group type: COMPARATOR
Intervention: Traditional learning approaches
Number of subjects: 0
Study 34710663 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal vmPFC and dlPFC stimulation with extracranial cathodal electrode
Number of subjects: 34
Study 34710663 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal dlPFC/cathodal vmPFC stimulation
Number of subjects: 34
Study 34710663 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the dlPFC with extracephalic return electrode
Number of subjects: 34
Study 34710663 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 34
Study 32269237 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE-L (Hypothermic Oxygenated Perfusion for Liver)
Number of subjects: 40
Study 32269237 — intervention group
Group type: COMPARATOR
Intervention: SCS-L (Static Cold Storage for Liver)
Number of subjects: 40
Study 32269237 — intervention group
Group type: COMPARATOR
Intervention: SCS-L
Number of subjects: 40
Study 32269237 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE-L
Number of subjects: 40
Study 32269237 — intervention group
Group type: COMPARATOR
Intervention: SCS-K (Static Cold Storage for Kidney)
Number of subjects: 40
Study 32269237 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE-K (Hypothermic Oxygenated Perfusion for Kidney)
Number of subjects: 40
Study 32269237 — intervention group
Group type: COMPARATOR
Intervention: SCS-K
Number of subjects: 40
Study 32269237 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE-K
Number of subjects: 40
Study 35738424 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise (65%-75% HRmax)
Number of subjects: 93
Study 35738424 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity aerobic exercise (75%-85% HRmax)
Number of subjects: 93
Study 35738424 — intervention group
Group type: COMPARATOR
Intervention: Quiet control group
Number of subjects: 93
Study 33265082 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Muscle Taping (TMT) group - kinesiology tape applied to erector spinae, latissimus dorsi, lower trapezius, internal oblique abdominis, and external oblique abdominis.
Number of subjects: 32
Study 33265082 — intervention group
Group type: COMPARATOR
Intervention: Erector Spinae Taping (EST) group - kinesiology tape applied only to the erector spinae.
Number of subjects: 32
Study 33265082 — intervention group
Group type: COMPARATOR
Intervention: Comparison between TMT and EST groups.
Number of subjects: 32
Study 34140596 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy and protein diet (HEP); ME intake 169.0 ± 1.4 MJ/day; CP intake 2.3 ± 0.02 kg/day
Number of subjects: 30
Study 34140596 — intervention group
Group type: COMPARATOR
Intervention: Low energy and protein diet (LEP); ME intake 92.9 ± 1.3 MJ/day; CP intake 1.0 ± 0.01 kg/day
Number of subjects: 30
Study 36062364 — intervention group
Group type: EXPERIMENTAL
Intervention: One-day multi-media training for teachers
Number of subjects: 311
Study 36062364 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 311
Study 34816682 — intervention group
Group type: EXPERIMENTAL
Intervention: Dienogest (Vissane 2 mg tablet)
Number of subjects: 90
Study 34816682 — intervention group
Group type: EXPERIMENTAL
Intervention: OCPs (LD)
Number of subjects: 90
Study 34816682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 33781234 — intervention group
Group type: COMPARATOR
Intervention: Control group (no calcium gluconate)
Number of subjects: 0
Study 33781234 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium 5 group (5 mg/kg calcium gluconate)
Number of subjects: 0
Study 33781234 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium 10 group (10 mg/kg calcium gluconate)
Number of subjects: 0
Study 33200989 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcement learning task with varying reward size and probability
Number of subjects: 0
Study 33200989 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing volatility in the learning task
Number of subjects: 0
Study 33200989 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of depressive symptoms
Number of subjects: 0
Study 34365959 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefrontal Cortex Transcranial direct current stimulation (tDCS)
Number of subjects: 225
Study 32808315 — intervention group
Group type: COMPARATOR
Intervention: First intervention
Number of subjects: 0
Study 32808315 — intervention group
Group type: COMPARATOR
Intervention: Second intervention
Number of subjects: 0
Study 32808315 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical test using specific intervention data
Number of subjects: 0
Study 32808315 — intervention group
Group type: EXPERIMENTAL
Intervention: Total number of periods and lag
Number of subjects: 0
Study 35087117 — intervention group
Group type: EXPERIMENTAL
Intervention: Family‐Based Empowerment Model (FECM) / Continuing Care Model (CCM)
Number of subjects: 0
Study 35087117 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed FECM and CCM rehabilitation techniques
Number of subjects: 0
Study 35087117 — intervention group
Group type: COMPARATOR
Intervention: Control group (D)
Number of subjects: 0
Study 33402159 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (started at 500 mg b.i.d. and escalated to 1000 mg b.i.d. after 2 weeks, maximum 2000 mg daily)
Number of subjects: 256
Study 33402159 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (with lifestyle intervention)
Number of subjects: 256
Study 33402159 — intervention group
Group type: COMPARATOR
Intervention: Placebo (with lifestyle intervention)
Number of subjects: 256
Study 35617960 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational video used to supplement standard in-person verbal and written consent
Number of subjects: 82
Study 35617960 — intervention group
Group type: COMPARATOR
Intervention: Standard informed consent process (without video)
Number of subjects: 82
Study 32183708 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive, complex psychological intervention commenced early in ICU
Number of subjects: 113
Study 35718205 — intervention group
Group type: EXPERIMENTAL
Intervention: VLA2001 high dose
Number of subjects: 153
Study 35718205 — intervention group
Group type: EXPERIMENTAL
Intervention: VLA2001 medium dose
Number of subjects: 153
Study 35718205 — intervention group
Group type: EXPERIMENTAL
Intervention: VLA2001 low dose
Number of subjects: 153
Study 35718205 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 153
Study 35718205 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses
Number of subjects: 153
Study 34730529 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined administration of intravenous (IV) and local tranexamic acid (TXA)
Number of subjects: 90
Study 34730529 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) tranexamic acid (15mg/kg)
Number of subjects: 90
Study 34730529 — intervention group
Group type: COMPARATOR
Intervention: Local tranexamic acid (2g)
Number of subjects: 90
Study 34730529 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined administration of IV and local tranexamic acid
Number of subjects: 90
Study 34857710 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-step approach to improve nonadherence (identification of nonadherent patients, determination of underlying causes, personalized solution)
Number of subjects: 3
Study 34857710 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored feedback tool for communication on drug levels
Number of subjects: 3
Study 33838657 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (2 mg/kg/day)
Number of subjects: 86
Study 33838657 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (6 mg/day)
Number of subjects: 86
Study 37145232 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (2 mg/day, increased by 1 mg/day, max 12 mg/day)
Number of subjects: 60
Study 37145232 — intervention group
Group type: COMPARATOR
Intervention: Combination of terlipressin (2 mg/day) and noradrenaline (starting at 0.5 mg/h, increased to 3 mg/h)
Number of subjects: 60
Study 33569809 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal exposure to PM2.5 during Spring Festival
Number of subjects: 156
Study 33569809 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure measurements during Spring Festival
Number of subjects: 156
Study 33569809 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors affecting PM2.5 exposure
Number of subjects: 156
Study 33569809 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) association with PM2.5 exposure
Number of subjects: 156
Study 32966280 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo treatment
Number of subjects: 90
Study 32966280 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 90
Study 36068369 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime&Bond Active (PB) with etch-and-rinse (ER) strategy
Number of subjects: 176
Study 36068369 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime&Bond Active (PB) with self-etch (SE) strategy
Number of subjects: 176
Study 36068369 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick (CQ) with etch-and-rinse (ER) strategy
Number of subjects: 176
Study 36068369 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick (CQ) with self-etch (SE) strategy
Number of subjects: 176
Study 36068369 — intervention group
Group type: COMPARATOR
Intervention: Self-etch (SE) strategy
Number of subjects: 176
Study 36068369 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime&Bond Active (PB) with self-etch (SE)
Number of subjects: 176
Study 36068369 — intervention group
Group type: COMPARATOR
Intervention: Clearfil Universal Bond Quick (CQ) with self-etch (SE)
Number of subjects: 176
Study 34843372 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% VAB
Number of subjects: 17
Study 34843372 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% VAB
Number of subjects: 17
Study 34843372 — intervention group
Group type: EXPERIMENTAL
Intervention: Summary VAB
Number of subjects: 17
Study 36460978 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM with COG
Number of subjects: 22
Study 36460978 — intervention group
Group type: COMPARATOR
Intervention: Model based reconstruction (MB group)
Number of subjects: 22
Study 34969668 — intervention group
Group type: EXPERIMENTAL
Intervention: AI intervention
Number of subjects: 23
Study 34969668 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care interventions
Number of subjects: 23
Study 35280707 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine combined with mechanical ventilation
Number of subjects: 136
Study 35280707 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 136
Study 33719268 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndecan-1 overexpression group (fumigation after injection of 1 mg/ml lipopolysaccharide, and transfection of 100 μl carrying rat syndecan‐1 gene Ad‐CMV‐GFP‐SDC1, n=10)
Number of subjects: 30
Study 33719268 — intervention group
Group type: COMPARATOR
Intervention: COPD group (fumigation after injection of 1 mg/ml lipopolysaccharide, transfection of 100 μl empty virus, n=10)
Number of subjects: 30
Study 33719268 — intervention group
Group type: COMPARATOR
Intervention: Sham operation group (normal saline injection after tracheal exposure, n=10)
Number of subjects: 30